Next Generation Gene Therapeutics Funding: $30M Raised
Next Generation Gene Therapeutics is based in California. It has raised $30M in total funding. Latest round: Series A.
Next Generation Gene Therapeutics funding overview
Next Generation Gene Therapeutics is based in California. Next Generation Gene Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Next Generation Gene Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Kington Capital, Weidu Capital, Northern Light Venture Capital, YuanBio Venture Capital. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Next Generation Gene Therapeutics funding
How much has Next Generation Gene Therapeutics raised?
Next Generation Gene Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Next Generation Gene Therapeutics?
Kington Capital, Weidu Capital, Northern Light Venture Capital, YuanBio Venture Capital are named among the investors backing Next Generation Gene Therapeutics.
What was the latest Next Generation Gene Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2021.
Where is Next Generation Gene Therapeutics based?
Next Generation Gene Therapeutics is based in California.
When did Next Generation Gene Therapeutics last raise?
The last disclosed Next Generation Gene Therapeutics round closed in April 2021 at Series A.
We update the Next Generation Gene Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in California and their backers are listed below.
Companies related to Next Generation Gene Therapeutics (19)
